Literature DB >> 14666735

Role of mannan-binding protein, MBP, in innate immunity.

Tomoaki Nakagawa1, Bruce Yong Ma, Kazuhide Uemura, Shogo Oka, Nobuko Kawasaki, Toshisuke Kawasaki.   

Abstract

Mannan-binding protein (MBP) is a C-type lectin, which binds to carbohydrates on the surface of some microorganisms and kills them through the activation of complement. This complement activation pathway is called the lectin pathway. MBP also kills mammalian cells that express MBP ligands on their surfaces via the lectin pathway. Recently, we found anti-tumor activity of MBP in vivo using tumor cells transplanted into nude mice. We propose to call this anti-tumor effect mannan-binding protein-dependent cell-mediated cytotoxicity (MDCC), because it does not require complement activation, and the involvement of some immune cells was assumed. Very recently, MBP was demonstrated to be selectively expressed in epithelial cells of the small intestine. This finding may suggest that MBP plays an important role in the small intestine as a host defense factor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14666735

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  3'-UTR and functional secretor haplotypes in mannose-binding lectin 2 are associated with increased colon cancer risk in African Americans.

Authors:  Krista A Zanetti; Majda Haznadar; Judith A Welsh; Ana I Robles; Bríd M Ryan; Andrew C McClary; Elise D Bowman; Julie E Goodman; Toralf Bernig; Stephen J Chanock; Curtis C Harris
Journal:  Cancer Res       Date:  2012-01-26       Impact factor: 12.701

2.  DNA methylation and exposure to violence among African American young adult males.

Authors:  Forough Saadatmand; Katherine Gurdziel; Latifa Jackson; Bernard Kwabi-Addo; Douglas M Ruden
Journal:  Brain Behav Immun Health       Date:  2021-03-29

3.  A population-based study of morbidity and mortality in mannose-binding lectin deficiency.

Authors:  Morten Dahl; Anne Tybjaerg-Hansen; Peter Schnohr; Børge G Nordestgaard
Journal:  J Exp Med       Date:  2004-05-17       Impact factor: 14.307

4.  Plasma Proteome Signature to Predict the Outcome of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.

Authors:  Sungchan Gwark; Hee-Sung Ahn; Jeonghun Yeom; Jiyoung Yu; Yumi Oh; Jae Ho Jeong; Jin-Hee Ahn; Kyung Hae Jung; Sung-Bae Kim; Hee Jin Lee; Gyungyub Gong; Sae Byul Lee; Il Yong Chung; Hee Jeong Kim; Beom Seok Ko; Jong Won Lee; Byung Ho Son; Sei Hyun Ahn; Kyunggon Kim; Jisun Kim
Journal:  Cancers (Basel)       Date:  2021-12-14       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.